News

Subscribe to our newsletter

Trade Secrets Theft In Life Sciences

Examples of Trade Secrets In Life Sciences The term trade secret refers to intellectual property—including but not limited to an idea, pattern, formula, or process—that

Shashank Upadhye September 28, 2020

FDA’s 505(b)(2) Application

The 505(b)(2) new drug application (NDA) is an attractive regulatory and commercial strategy for clients. This hybrid NDA application helps avoid duplicative and costly studies

Shashank Upadhye September 28, 2020

Staying Compliant with FDA’s Good Manufacturing Practice (GMP), and Handling Violations

We concentrate a large part of our work helping clients to solve legal problems when dealing with FDA compliance. Particularly, we help clients comply with the

Shashank Upadhye September 27, 2020

Patents

Hatch-Waxman Litigation

Trade Secrets

Antitrust/Unfair Competition

FDA Counseling

Branded/Generic/ 505(b)(2)

Life Cycles

Contracts Licensing

Freedom to Operate

News

Subscribe to our newsletter

Trade Secrets Theft In Life Sciences

FDA’s 505(b)(2) Application

Staying Compliant with FDA’s Good Manufacturing Practice (GMP), and Handling Violations

Quick Contact

Address

Ⓒ 2021 - IPFDA law All Rights Are Reserved